Skip to main content

Table 2 Effects of Rimonabant with dietary intervention on daily energy and macronutrient intake before and after intervention (n = 18) (Mean ± SD)

From: Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant

Variable

Baseline

6 months

Energy (Kcal)

2225 ± 1109

1589 ± 384 **

Carbohydrate (g)

273 ± 194

199 ± 74 *

Protein (g)

98 ± 36

78 ± 23 *

Fat (g)

84 ± 39

55 ± 18 **

Starch (g)

148 ± 48

114 ± 36 *

Sugar (g)

121 ± 171

74 ± 64

Non-starch polysaccharide (g)

18 ± 5

14 ± 3 **

Saturated fatty acids (g)

30 ± 16

20 ± 6 **

Monounsaturated fatty acids (g)

29 ± 12

19 ± 7 **

Polyunsaturated fatty acids (g)

16 ± 8

10 ± 4 **

  1. *p < 0.05 in comparison to baseline.
  2. **p < 0.01 in comparison to baseline.